
Wed Apr 01 07:22:56 UTC 2026: ### U.S. Accuses India of High Import Duties and Trade Barriers in Annual Report
The Story:
The United States Trade Representative’s (USTR) 2026 National Trade Estimate (NTE) Report, released on March 31, 2026, has once again criticized India for maintaining “high” import duties on various goods, including agricultural products, pharmaceuticals, and alcoholic beverages. The report also highlights non-tariff barriers, intellectual property concerns, and restrictions on digital trade as ongoing challenges. India maintains that its duties are compliant with World Trade Organisation (WTO) rules.
Key Points:
- The USTR report alleges that India’s high applied tariffs on goods like vegetable oils (45%), apples, corn, motorcycles (50%), automobiles, flowers (60%), natural rubber (70%), coffee, raisins, walnuts (100%), and alcoholic beverages (150%) create uncertainty for U.S. exporters.
- The report criticizes India’s “very high” basic customs duties on drug formulations, including life-saving drugs.
- India’s WTO bound tariff rates on agricultural products average 113.1%, reaching as high as 300%.
- The report acknowledges that India’s 2026 budget reduced applied tariffs on certain products, including life-saving medicines and components for electric vehicles.
- The U.S. raises concerns about India’s non-tariff barriers, including import bans, restrictions, licensing requirements, mandatory Quality Control Orders (QCOs), and domestic testing requirements.
- The report also highlights concerns regarding India’s intellectual property policies, services sector restrictions, and barriers to digital trade.
Key Takeaways:
- Trade tensions between the U.S. and India persist, primarily due to differing perspectives on tariff levels and trade practices.
- The USTR report serves as a formal mechanism for the U.S. to voice its concerns and potentially influence India’s trade policies.
- Despite some tariff reductions in India’s 2026 budget, significant trade barriers remain, according to the U.S.